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MDMA AND MEMORY: THE ACUTE AND CHRONIC EFFECTS
OF MDMA IN PIGEONS PERFORMING UNDER A DELAYEDMATCMNG-TO-SAMPLE PROCEDURE
Mark LeSage, M.A.
Western Michigan University, 1992
The physiological effects o f (+) 3,4-m ethylenedioxym etham phetam ine
(MDMA) have been studied extensively. The behavioral effects of MDMA, however,
have not been examined in detail. In an attempt to gain further information about its
behavioral effects, the acute and chronic effects of MDMA were examined in pigeons
responding under a delayed-matching-to-sam ple procedure with 0-, 3-, and 6-s
delays. In the absence o f drug, accuracy (percentage o f correct responses) was
inversely related to delay length. When administered pre-chronically, MDMA (0.32
to 5.6 mg/kg) decreased accuracy and response rates at higher doses. Tolerance
developed following chronic exposure to 3.2 mg/kg. Performance did not deteriorate
when the chronic regimen ended, indicating an absence of behavioral dependence on
the drug.
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CHAPTER I
INTRODUCTION
The Problem of Drug Abuse
Drug abuse is a pervasive problem in many cultures. In fact, no culture in
which drug use occurs is immune from the probable genesis and evolution o f drug
abuse as an epidemic. For example, in the United States, drug abuse is widespread.
There is evidence across all social classes, races, religions, age groups, and economic
levels that drug abuse potentially can infiltrate any facet o f a culture (Witters,
Venturelli, & Hansen, 1992). According to The National Household Survey on Drug
Abuse conducted by the National Institute on Drug Abuse (1988), a staggering 72.4
million Americans age 12 or older have tried an illicit drug at least once in their lives.
The United States alone consumes about 60 percent of the world's production of
illegal drugs (Schlaadt, 1992). Few would argue that abuse o f legal and illegal drugs
is a nationwide problem in the United States. Billions of dollars are spent every year
on enforcement and treatment o f drug abuse alone. Moreover, some o f the most
troublesome daily events in America, such as spousal abuse, suicides, assaults, rapes,
child abuse, drownings, traffic fatalities, and murders, are often associated with the
abuse o f alcohol and other drugs (Payne, Hahn, & Pinger, 1991). As Steven Jay
Gould (1992) vividly portrayed:
A t the moment, hundreds o f thousands o f drug users live in tortured
limbo, driven to crime, exposed to AIDS, and doomed (at least
statistically speaking) to early death. M illions o f others suffer
palpably from the deeds of the addicted—experiencing violence,
robbery, or simple urban fear that steals the joy from life. Billions of
dollars go down the rathole to enrich the entrepreneurs or try to stem
the plague by necessarily ineffective interdiction. The politics of

1
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several nations in our hemisphere are corrupted, the cultures of whole
peoples severely compromised, (p. 33).
Some o f the specific drugs o f abuse that are often associated with the
problem s m entioned above are alcohol, the m ajor stim ulants (e.g, cocaine,
amphetamine), the narcotics (e.g., heroin, morphine), cannabis (e.g., marijuana,
hashish), and the hallucinogens (e.g., LSD, mescaline, phencyclidine). Designer
drugs, which are synthetic derivatives o f federally controlled substances, are among
the most popular contemporary drugs of abuse and becoming a major problem in the
United States (Beebe & Walley, 1991).
Designer Drugs
Designer drugs are essentially slight variations on already federally controlled
substances and are designed to mimic the effects of the drugs from which they were
derived. They are capable of being ten to one thousand times stronger than their
parent compounds (Maisto, Galizio, & Conners, 1991). For example, alpha-methylfentanyl is 200 times stronger than morphine (Beebe & Walley, 1991). Designer
drugs prim arily encompass three main drug classes: stimulants, narcotics, and
hallucinogens (Kirsch, 1986). Three o f the more common categories o f designer
drugs are the synthetic opioids, phenylethylam ines (m escaline analogs), and
arylhexylamines.

Crack, a form o f cocaine, is now considered a designer drug

because of its increasing availability and popularity, even though it does not fit into
the chemical categories mentioned above (Beebe & Walley, 1991). Table 1 lists some
o f the popular designer drugs and their effects on users.
In the past, designer drugs, when first synthesized, were not controlled by
federal law. That is, each time a new drug was discovered, law enforcement officials
had to go through a lengthy bureaucratic process to have the new drug certified as a
controlled substance (Maisto et al., 1991). In the meantime, drug dealers were able to
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Table 1
Effects o f Common Designer Drugs
Drug

Category

Effects on User

Alpha-methyl-fentanyl
("china white")

Synthetic Opioid

Analgesia, euphoria, drowsiness
respiratory depression, muscle
rigidity, constipation

3,4-Methylenedioxyamphetamine (MDA,
"love drug")

Phenylethylamine

Euphoria, feelings o f empathy
without hallucinations

3,4-Methy lendioxymethamphetamine
(MDMA, "ecstacy")

Phenylethylamine

Euphoria, feelings of empathy,
increased self-esteem, mild visual
hallucinations, heightened sense
of touch

Dextrometh amphetamine
("ice")

Phenylethylamine

Euphoria, impulsiveness,
paranoia

Phencyclidine (PCP,
"angel dust")

Arylhexylamine

Euphoria, feeling of dissociation,
aggression, analgesia, paranoia,
hallucinations

Crack

Cocaine derivative

Euphoria, grandiosity, hyper
vigilance, psychomotor agitation

bypass the Food and Drug Administration's list o f restricted drugs and market an
essentially legal drug (Evanko, 1991). Moreover, given this brief foreperiod of legal
status, drug dealers hastily produced large quantities o f their designer drugs and
distributed them widely to maximize profits. In the midst o f this bustling production,
no attempt was made at testing these new drugs to determine potential deleterious side
effects in users. As a result, some drugs with marked toxicity were produced and
marketed. For example, a synthetic opiate known as MPTP (l-m ethyl-4-phenyl1,2,3,6-tetrahydropyridine) is toxic to brain cells in the substatia nigra. Numerous
cases have been reported o f MPTP users experiencing severe Parkinsonian effects
(Kirsch, 1986). In response to law enforcement agencies' difficulties in controlling
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the production o f designer drugs and the harmful side effects that some o f these drugs
produce, Congress in 1986 passed the Controlled Substances Analogue Enforcement
Act, which allowed for the immediate classification of a novel drug as a controlled
substance (Maisto et al.,1991). However, there still exists an unavoidable "grace
period" between production o f a new drug and its subsequent federal control, as
enforcement agencies often lack assays sensitive enough to detect novel compounds
(Payne et al., 1991). Thus, the production o f designer drugs continues.
M aisto et al. (1991) make two important points regarding the dangers o f
designer drugs:
[T]he tremendous hazard associated with designer drugs is obvious.
Because these drugs are not tested in animals and screened by the
FDA, the risks they pose to the user are great. An additional point is
that brain damage can occur without overt symptoms. Many people
who were exposed to M PTP only once or twice probably do not
show any Parkinson symptoms at present. N onetheless, some
damage to the substantia nigra has occurred. As more cells are lost
during the normal aging process, the 80% threshold may be reached
and these individuals may yet pay the price by developing premature
Parkinsonism, (p. 67)
The above quote identifies the importance o f thoroughly testing novel drugs.
For example, had MPTP been tested before it was marketed, many people may have
been spared the agony o f Parkinsonian symptoms, if not their very lives. That is,
had drug users been aware of the harmful effects o f MPTP, they may not have
bothered trying it. Other designer drugs have become very popular, yet little is
known about their physiological and behavioral effects. One designer drug, MDMA
(3,4-methylenedioxymethamphetamine), has generated much interest recently. It was
first synthesized in the early 1900s, but only recently have researchers begun to
examine this interesting compound under controlled experimental conditions. While
researchers are gaining a better understanding of MDMA's physiological effects, the
behavioral effects o f MDMA have not been examined as extensively.
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Review of MDMA Literature
MDMA is a synthetic amphetamine analog that reportedly has both stimulant
and hallucinogenic properties (Callahan & Appel, 1988; Evans & Johanson, 1986;
Schechter, 1986). In the past five years, interest has increased in MDMA, largely
because o f its documented recreational use in humans (Peroutka, 1987; Siegel, 1986),
significant potential for abuse (Lamb & Griffiths, 1987), and neurotoxicity to
serotonergic systems in rat and nonhuman primate brains (e.g., Commins et al.,
1987; Ricaurte et al., 1988; Schmidt, 1987; Stone, Stahl, Hansen, & Gibb, 1986).
MDMA also is interesting because of its previous use as an adjunct to psychotherapy
due to its reported ability to produce "positive mood changes and enhance intimacy
and communication" (Lamb & Griffiths, 1987, p. 268).
The physiological effects o f MDMA have been studied extensively.
Researchers have examined the drug's pharmacology (e.g., Lyon, Glennon, Titeler,
1986), toxicology (e.g., Commins et al., 1987), and metabolism (e.g., Yousif et al.,
1990). The behavioral effects of MDMA, however, have not been examined in detail.
An exception concerns the ability of the drug to serve as a discriminative stimulus or
to substitute for other drugs established as discriminative stimuli. Several studies in
this area have appeared. For example, in rats tested under drug-discrimination
assays, the subjective effects of MDMA were more mescaline-like than LSD-like
(Callahan & Appel, 1987). At certain doses, MDMA produced amphetamine-like
patterns o f responding in rats (Glennon & Young, 1984), pigeons (Evans &
Johanson, 1986), and monkeys (Kamien, Johanson, Schuster, & Woolverton, 1986)
trained to discriminate saline from amphetamine.
Few studies have examined the effects o f MDMA on schedule-controlled
responding. In mice, acute administrations of MDMA decreased response rates
maintained under a fixed-ratio 20 (FR 20) schedule of food delivery in generally dose-
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dependent fashion (Glennon, Little, Rosecrans, & Yousif, 1987; Rosecrans &
Glennon, 1987). In pigeons, the drug when given acutely produced dose-dependent
decreases in response rates under both components of a multiple fixed-ratio 30 fixedinterval 3-min (FR 30 FI 3-min) schedule o f food delivery (Nader, Hoffmann, &
Barrett, 1989). Acute administrations o f MDMA also decreased rate o f responding in
monkeys performing under a repeated acquisition procedure, although the drug did
not affect learning or performance accuracy (Thompson, Winsauer, & Mastropaolo,
1987).
Only two studies have examined how chronic administration influences the
behavioral effects of MDMA. In one (Zacny, Virus, & Woolverton, 1990), MDMA
initially reduced milk drinking by mice. Tolerance appeared when the drug (2.5, then
5 mg/kg) was administered either 15 min before or 15 min after daily milk-drinking
sessions.
In a second study involving chronic exposure, acute adm inistrations o f
MDMA increased response rates and reduced reinforcement rates in rats responding
under an interresponse-time-greater-than-72-s (IRT > 72-s) schedule (Li, Marek,
Vosmer, & Seiden, 1989).

D uring the chronic phase, 6 mg/kg MDMA was

adm inistered every 12 hours for 4 days.

Acute dose-response relations were

redetermined four weeks after chronic exposure. Effects were greater during post
chronic determinations than during pre-chronic determinations (i.e., sensitization
occurred).
It is not clear why chronic exposure to MDMA produced tolerance in the milkdrinking task studied by Zacny et al. (1990) and sensitization under the IRT > 72-s
schedule examined by Li et al. (1989). Behavioral assays, species, and dosing
regimens differed in the two studies, and any of these differences may have accounted
for the dissimilar results.
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Purpose o f the Present Study
In an attempt to gain further information about the behavioral effects o f
MDMA, the present study explored the acute and chronic effects o f the drug in
pigeons responding under a delayed-matching-to-sample (DMTS) procedure. This
procedure was employed because of its sensitivity to the effects of a range o f drugs
(Thompson, 1978) and is commonly considered as an assay o f short-term memory
(Heise & Milar, 1984).

It requires subjects to match stimuli (e.g., key colors)

separated in time by different delay intervals (e.g., 0, 3, or 6 s.) and has provided
valuable information concerning the effects o f many drugs on stimulus-controlled
responding (Thompson, 1986).
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CHAPTER II
METHODS
Subjects
Four White Cameau pigeons, maintained at 80-85% o f their free-feeding body
weights, served as subjects. One bird (B4) was experimentally naive. The other
three (B5, B6, B7) had histories o f responding under a DMTS procedure like that
used in the present study and had been acutely exposed to hallucinogenic drugs.
These three pigeons were drug free for at least six months prior to the start o f the
present experiment. Each bird was individually housed with unlimited access to grit
and water.
Apparatus
Four Lehigh Valley Electronics (BRS/LVE, Lehigh Valley, PA) operant
conditioning chambers, measuring 32 cm long, 36 cm high, and 35 cm wide, were
used. In each chamber, three response keys 2.5 cm in diameter were located 23 cm
from the bottom of the intelligence panel approximately 5.5 cm apart. A minimum of
0.2 g pressure was required for key operation. Each key could be illuminated in red
or green. An aperture horizontally centered on the front wall 7.5 cm above the floor
allowed access to a hopper filled with mixed grain when the hopper is raised. When
raised, the hopper was illuminated by a 7-W white bulb. A 7-W bulb (houselight)
centrally mounted in the ceiling of the chamber provided ambient illumination. White
masking noise was constantly provided. A fan mounted on the back wall o f the
chamber provided continuous ventilation. A Digital Equipment Coip. (Maynard, MA)
8
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PDP8/E minicomputer using interface and SUPERSKED software (Snapper & Inglis,
1978) provided by State Systems (Kalamazoo, MI) was used for scheduling o f
experimental events and collecting data.
Behavioral Procedure
Although three o f the subjects had experience under the DMTS procedure, all
subjects were exposed to the same training procedures. Prior to the start o f the
experiment proper, the birds were hopper trained, then exposed to a forward pairing
autoshaping procedure similar to that described by Brown and Jenkins (1968). Once
keypecking was reliably established during red and green illuminations on all three
keys, the birds were exposed to the DMTS procedure.
Under this procedure, discrete trials were programmed with an 8-s intertrial
interval (ITI). Each trial began with a 0.25-s darkening o f the chamber, after which
the center key was illum inated in red or green (i.e., the sample stim ulus was
presented).

W ith the exceptions o f the 0.25 periods that preceded sample

presentations and timeouts (see below), the chamber was constantly illuminated. The
sample color presented on each trial was selected at random with the exception that red
and green were presented equally often during each block o f 12 trials. A single
response to the center key extinguished the sample stimulus and initiated a delay
interval o f 0, 3, or 6 s. The delay interval arranged on each trial was selected at
random, with the exception that each of the three possible delays appeared equally
often each session.

At the end o f the delay interval, the two side keys were

illuminated (i.e., the comparison stimuli were presented) in one o f two randomlydetermined configurations: red on the left key and green on the right or vice versa. A
response to the comparison stimulus that matched the sample stimulus in color
resulted in darkening o f the side keys and 3-s access to grain, followed by the ITI.
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Nonmatching responses (errors) were followed by darkening o f the chamber for 2 s
(timeout). After the timeout, the houselight was illuminated and the ITI initiated.
N onm atching trials were repeated until the pigeon responded to the correct
comparison stimulus. These correction trials were intended to prevent the pigeon
from developing a position preference (in the absence o f such a procedure the pigeon
could obtain 50% of the available reinforers by simply responding on one or the other
side key).
When the percentage of correct responses [(matching responses / matching
responses + nonmatching responses) x 100)] showed no visually evident trend across
10 consecutive sessions, the response requirement for extinguishing the sample
stimulus was gradually increased to 5, and only every other correct trial was followed
by food delivery. Correct trials not followed by food were followed by a 0.5-s flash
o f the hopper light (a putative conditioned reinforcer) and the ITI. Trials were aborted
(terminated) if a subject failed to respond to one the side keys within 30 s of
presentation of the comparison stimuli, or failed to complete the response requirement
on the center key within 30 s. Aborted trials were repeated after an 8-s ITI and were
not recorded as incorrect. During the experiment proper, sessions were terminated
after 140 trials or 50 min, whichever came first. During determination o f acute drug
effects, sessions usually were conducted six days per week at about the same time
each day. During chronic exposure, sessions were conducted daily.
Pharmacological Procedure
Initial dose-response determination began when (a) each bird had received at
least 60 sessions of exposure to the DMTS procedure, and (b) there was no visually
evident trend in the percentage o f correct responses for each bird for 10 consecutive
sessions. The acute effects o f six doses o f MDMA (0.32, 1.0, 1.7, 3.2, 4.2, and 5.6
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mg/kg) were determined.

MDMA (Sigma Chemical Co., St. Louis, MO) was

dissolved in a vehicle o f 0.9% saline solution, prepared at an injection volume of 1
ml/kg.

Throughout the experiment, drug and vehicle control injections were

administered 10 min prior to experimental sessions. Doses and presession injection
times were selected on the basis o f previous reports (Evans & Johanson, 1986; Nader
et al., 1989) and pilot data from our laboratory. Each bird received at least two, but
no more than three, administrations o f every dose. A dose was administered a third
time only in the event that the effect o f the second administration was markedly
different from the first administration. This occurred in four cases. Bird B4 received
three administrations of 5.6 mg/kg, B6 received three administrations o f 4.2 and 5.6
mg/kg, and B7 received three administrations o f 4.2 mg/kg. For each bird, doses
were administered in a random order according to a BBCDBBCD design, where B
represents baseline sessions, C represents vehicle control sessions, and D represents
drug sessions.
Following completion o f the acute dose-effect determinations, the chronic
effects o f MDMA were determined. Here, each subject first received at least 10
baseline sessions followed by two vehicle control sessions, then chronic exposure to
MDMA. The lowest dose that produced obvious behavioral impairment without
completely suppressing responding during the acute phase was selected as the chronic
dose. Thus, 3.2 mg/kg served as the chronic dose. Following 20 days of daily
exposure to 3.2 mg/kg, subjects were exposed to a 4.2 mg/lcg challenge dose on a
single occasion. Subjects then received five consecutive sessions of exposure to 3.2
mg/kg. A 5.6 mg/lcg challenge dose was then administered on a single occasion. To
determine the effects of MDMA withdrawal, subjects then received 10 vehicle control
sessions followed by 5 days of 3.2 mg/kg, then 5 vehicle control sessions.
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CHAPTER IH
RESULTS
Pre-Chronic Performance
Pre-chronic dose-response curves for accuracy and response rates will be
considered initially. Figure 1 shows group performance for overall accuracy at each
delay value as a function of dose o f MDMA. Data shown are the percentage of correct
responses averaged across the four subjects during pre-chronic control sessions,
during acute exposure to each dose, during control sessions immediately prior to the
chronic regimen, during the final session of exposure to the chronic dose, and during
exposure to the two challenge doses. Figures 2 and 3 show each subject's accuracy at
each delay value. Data shown are the average percentage of correct responses across
two dose-effect determinations at each dose o f MDMA during pre-chronic control
sessions, during acute exposure to each dose, during control sessions immediately
prior to the chronic regimen, during the final session of exposure to the chronic dose,
and during exposure to the two challenge doses. MDMA was considered to affect
behavior (accuracy or response rate) if performance at a given dose was outside the
range of values encompassed by the vehicle control mean + one standard error. If a
subject completed fewer than 30 trials (10 trials at each delay value) during any drug
session, responding was considered suppressed below a level neccesary to assess
accuracy meaningfully. Data from such sessions are not included. These sessions
with no data made it impossible to analyze results via conventional inferential statistics
(e.g., an ANOVA followed by planned comparisons), thus no statistical analysis was
attempted.

12
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Figure 1. Pre- and Post-Chronic Effects o f MDMA on Percentage o f Correct
Responses at Each Delay Under a DMTS Procedure Averaged Across A ll
Subjects.
Each point in the dose-response curve is the mean performance o f four pigeons. The
points at C indicate the mean for control (saline) sessions. Vertical lines indicate
standard errors o f the mean. Points without vertical lines indicate an instance in
which the standard error is encompassed by the point.
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Pre- and Post-Chronic Effects of MDMA on Percentage o f Correct
Responses at Each Delay Under a DMTS Procedure for Birds 4 and 5.

The points at C indicate the mean for control (saline) sessions. Vertical lines indicate
standard errors o f the mean. Points without vertical lines indicate either a single
determination (i.e., where the second and/or third determination suppressed
responding below the minimum trial requirement) or an instance in which the standard
error is encompassed by the point. Points have been omitted at doses where
responding was suppressed below the minimum trial requirement at all determinations
(e.g., 4.2 and 5.6 mg/kg).
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Pre- and Post-Chronic Effects o f MDMA on Percentage o f Correct
Responses at Each Delay Under a DMTS Procedure for Birds 6 and 7.

The points at C indicate the mean for control (saline) sessions. Vertical lines indicate
standard errors o f the mean. Points without vertical lines indicate either a single
determination (i.e., where the second and/or third determination suppressed
responding below the minimum trial requirement) or an instance in which the standard
error is encompassed by the point. Points have been omitted at doses where
responding was suppressed below the minimum trial requirement at all determinations
(e.g., 5.6 mg/kg).
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In the absence o f drug, the percentage o f correct responses decreased as a
function o f increasing delay values. For subjects as a group, MDMA at doses above
3.2 mg/kg produced dose-dependent decreases in the average percentage o f correct
responses, but decreases in accuracy did not reach chance levels (i.e., 50%) at any
dose. In general, results with individual subjects were similar to those evident in
mean group performance, although high doses produced somewhat variable effects
across subjects. For instance, 4.2 mg/lcg produced significant reductions in accuracy
relative to control in B5 whereas B6 was little affected by that dose.
Figures 4 and 5 show the effects o f MDMA on rates o f responding
(responses/minute) to the sample stimulus (i.e., the center key). Data shown are
average rates for subjects as a group (Figure 4) and as individuals (Figure 5). The
data represent response rates during pre-chronic control sessions, during acute
exposures to each dose, during control sessions immediately prior to the chronic
regim en, during the final session o f exposure to the chronic dose, and during
exposure to each challenge dose. A t doses above 3.2 mg/kg, MDMA produced
generally dose-dependent decreases in response rates for subjects as a group. Doses
o f 3.2 mg/kg or higher reduced rates below control levels in all individual subjects.
Responding o f all subjects was com pletely suppressed at 5.6 mg/kg.

MDMA

completely suppressed responding in B4 at both determinations of 4.2 mg/kg, and at
one o f two determinations in B6 and B7.
Post-Chronic Performance
In general, tolerance developed to both the accuracy- and rate-reducing effects
o f MDMA following repeated exposure to 3.2 mg/kg. This effect is readily apparent
in Figures 1 and 4, which show that, for subjects as a group: (a) the accuracy- and
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Figure 4. Pre- and Post-Chronic Effects of MDMA on Rates of Responding Under a
DMTS Procedure Averaged Across All Subjects.
Each point in the dose-response curve is the mean performance of four birds. The
points at C indicate the mean for control (saline) sessions. Vertical lines indicate
standard errors o f the mean.
rate-reducing effects o f 3.2 mg/kg were smaller on the final day of chronic exposure
than during the pre-chronic dose-response determination, and (b) the accuracy- and
rate-reducing effects of 4.2 and 5.6 mg/kg were smaller when these doses were given
as challenges during the chronic regimen than when they were administered prechronically. Although considerable variability is apparent, tolerance to the accuracyand rate-reducing effects characteristically is evident in the performance o f individual
subjects (see Figures 2 and 3). Perhaps the strongest evidence of tolerance concerns
the effects of 5.6 mg/kg. This dose completely suppressed responding during initial
dose-response determinations, but 3 o f 4 subjects completed all of the possible trials
(i.e., 140) during the session when it was given post-chronically. The exception,
bird B7, did not show tolerance to the effects o f 5.6 mg/kg (i.e., this dose continued
to suppress performance completely following chronic exposure).
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Figure 5. Pre- and Post-Chronic Effects o f MDMA on Rates o f Responding Under a
DMTS Procedure for Individual Subjects.
Each graph represents data from a single bird. The points at C indicate the mean for
control (saline) sessions. Vertical lines indicate standard errors o f the mean. Points
without vertical lines indicate an instance in which the standard error is encompassed
by the point.
The magnitude o f tolerance that developed to the accuracy-reducing effects of
M DM A appeared to be dependent on the delay between sample presentation and onset
o f the com parison stimuli. In general, for three out o f four birds, greater tolerance
was observed at the 0-s delay than at the 6-s delay. Finally, perform ance did not
deteriorate when the chronic regim en ended, indicating an absence o f behavioral
dependence on MDMA.
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CHAPTER IV
DISCUSSION
In the present study, MDMA produced dose-dependent decreases in both
accuracy and response rates under the DMTS procedure. The rate-reducing effects
shown here are consistent with results reported with mice responding under an FR 20
schedule (Glennon et al., 1987; Rosecrans & Glennon, 1987) and in pigeons
responding under a multiple FR 30 FI 3-min schedule (Nader et al., 1989). They are
also in agreement with results reported by Thompson et al. (1987), who demonstrated
that acute administrations o f MDMA decreased the rate o f responding in monkeys
performing under a repeated aquisition procedure. However, the accuracy-reducing
effects shown here are inconsistent with the Thompson et al. (1987) findings, which
indicated that MDMA did not affect learning or performance accuracy. Why MDMA
reduced accuracy under the DMTS procedure in the present study and not under the
repeated aquisiton procedure used by Thompson et al. (1987) is not obvious.
Differences in the behavioral assays, species, and dosing regimens employed in the
two studies could account for the disparate results.
The results of the present study also show that tolerance developed to both the
accuracy- and rate-reducing effects of MDMA. This finding is consistent with the
results of a prior study, which demonstrated tolerance to MDMA-induced reductions
in milk drinking by mice (Zacny et al., 1990). However, the present results are
inconsistent with the results of a prior study in which sensitization was observed
following repeated administration o f MDMA under an IRT>72-s schedule of food
delivery (Li et al., 1989). Interestingly, in all studies that have examined possible
19
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tolerance to the behavioral effects of MDMA, the effect o f the drug when administered
pre-chronically was reinforcement loss, thus the difference in the findings cannot be
explained in terms o f the reinforcement-loss hypothesis (Schuster et al., 1966).
The fact that tolerance developed to MDMA in two of three studies is of
interest, given that the drug is a neurotoxin to serotonergic and, to a lesser extent,
dopaminergic systems in rodent and primate brains (Commins et al., 1987; Ricaurte et
al., 1988; Schmidt, 1987; Stone et al.,1986). Although no biochemical assay was
employed in the present study to evaluate toxicity, the data presented here show that
if, in fact, MDMA produced toxic effects, they were not associated with long-lasting
or cumulative behavioral impairment under the DMTS procedure, since complete
recovery o f performance was observed when the chronic regim en ended.

It is

possible, however, that a more lengthy chronic regimen or administration of a higher
daily dose would have produced enduring behavioral impairment.
In the present study, the m agnitude o f tolerance that developed to the
accuracy-reducing effects of MDMA appeared to be a function o f the delay length
between presentation o f the sample and com parison stimuli.

This relation is

consistent with the results of a prior study that examined the effects o f cocaine on
DMTS performance in pigeons (Branch & Dearing, 1982) and is compatible with a
reinforcem ent-loss analysis of tolerance (Schuster, 1966). This analysis would
predict that the greater the loss o f reinforcement produced by a given dose of MDMA
relative to control, the greater the magnitude o f observed tolerance. Accuracy
(percentage o f correct responses) in the present study was directly related to the
number o f reinforcers obtained: Fifty percent of correct responses were followed by
food delivery, the remainder by a conditioned reinforcer (flash o f the hopper light).
The difference in accuracy under control and pre-chronic drug conditions was greater
at the 0-s delay than at the 6-s delay. Hence, more reinforcers were lost due to the
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effects o f the drug when the delay was 0 s. The larger proportional loss at the 0-s
delay may have contributed to the greater tolerance observed at that delay.
An alternative analysis is that stimulus control affected the development of
tolerance. Several studies indicate that the degree of stimulus control in the absence of
drug often modulates acute drug effects (Thompson, 1978), and other reports suggest
that it may also influence the development o f tolerance. For example, Rees, Wood,
and Laties (1987) found that the development of tolerance was facilitated when the
behavior o f rats performing under two variants of a fixed-consecutive-num ber
schedule was under discriminative control by external stimuli. In two other related
studies, Moerschbaecher, Boren, Schrot, and Fontes (1979) and Thompson (1977)
found that tolerance developed less rapidly to the performance-disrupting effects of damphetamine and cocaine, respectively, when pigeons were required to learn a
response sequence that changed daily (learning) than when the response sequence
remained constant from day to day (performance). Although the strength of stimulus
control was not directly measured in these studies, it was inferred from the error rates
under the two conditions (i.e., fewer errors under performance conditions were
interpreted as indicating stronger stimulus control). However, the effect of stimulus
control in the development o f tolerance was confounded by differential changes in
reinforcement frequency under the two conditions. That is, d-amphetamine initially
decreased reinforcement frequency more under performance conditions than under
learning conditions.

Thus, the m ore rapid developm ent o f tolerance under

perform ance conditions is readily predicted by a reinforcem ent-loss analysis
(Schuster, 1966). The present findings, as well as those reported by Branch and
Dearing (1982), are consistent with this observation in that stimulus control, as
indexed by the percentage of correct responses, was greater at the shortest delay than
at longer delays, and this variable may have affected the development o f tolerance.
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However, as mentioned above, reinforcement frequency differed across delay values.
Thus, both the reinforcem ent-loss and stimulus control analyses are plausible
accounts for the differential development o f tolerance across delay values. The
separate roles o f reinforcement frequency and degree o f stimulus control in the
development of tolerance to drug effects seems to warrant further study.
Finally, previous reports have suggested that, in humans, MDMA produces a
withdrawal sydrome characterized by drowsiness, muscle aches, depression, and
impairment o f concentration (Barnes, 1988). Therefore, it is possible that one would
observe behavioral impairment in nonhumans upon termination of chronic exposure to
MDMA. However, this did not occur in the present study. Performance during the
first and subsequent control sessions following chronic exposure was very close to
pre-chronic baseline levels. This finding is inconsistent with reports that "the drug
causes a distinct hangover and by the second day its negative side effects are
pronounced" in humans (Barnes, 1988, p. 864).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Appendix A
IACUC Approval

23

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

24

s..-';.

. •; *. i

/•-T: IN V E ST IG A TO R C E R T IF IC A T IO N S
Title

d zu h z a n d CAranfc
filth y/fS g d ib ty M^/JtawO/tySn/r'.

of

^
_______
//) tty

P ro je c t7 ^

II any ol the above

1

— ---------

' —

^

,

„ c ^ J t s /'e

I understand that any (ailure to comply with the A n im al W elfare Act, the provisions ol the D P H S G u ide
for the C a re a n d U se o f Laboratory A nim als and requirements set down by the IACUC may result in the
suspension of m in im a l studie"
-

w y j f s ___________

Signature: ' P rin cipa l'fn v ^ ilgato r

_

____________

:

nt

D a te

REVIEW BY THE INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE

X

D isapproved

A pproved

______ Approved with the provisions
listed below

Provisions:
or
Explanation

Q iU ^

IACUC C h a irp e rso n i

"J.rp' •; •

^

_______________________

lull'll8°l
D a te

R esearch er's Acceptartoo of Provisions:

Signature:

Principal Investigator

D a te

IACUC Chairperson Final Approval
Approved IACUC Num ber
R evised

O O

D a te

5 l . __________________

J u n e , 1988
A -6

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

BIBLIOGRAPHY
Barnes, D. M. (1988). New data intensify the agony over ecstacy. Science. 239.
864-866.
Beebe, D. K., & Walley, E. (1991). Substance abuse: The designer drugs.
American Family Physician. 43. 1689-1698.
Branch, M. N., & Dearing, M. E. (1982). Effects of acute and daily cocaine
administration on performance under a delayed-matching-to-sample
procedure. Pharmacology Biochemistry and Behavior. 16. 713-718.
Brown, P. L., & Jenkins, H. M. (1968). Auto-shaping o f the pigeon's key-peck.
Journal o f the Experimental Analysis o f Behavior. 11. 1-8.
Callahan, P. M., & Appel, J. M. (1988). Differences in the stimulus properties of 34 methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in
animals trained to discriminate hallucinogens from saline. Journal of
Pharmacology and Experimental Therapeutics. 246. 866-870.
Commins, D. L., Vosmer, G., Virus, R. M., Woolverton, W. L., Schuster, C. R.,
& Seiden, L. S. (1987). Biochemical and histological evidence that
methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat
brain. Journal o f Pharmacology and Experimental Therapeutics. 241. 338345.
Evanko, D. (1991). Designer drugs: Treating the damage caused by basement
chemists. Postgraduate Medicine. 89. 67-70.
Evans, S., & Johanson, C. E. (1986). Discriminative stimulus properties of (+)3,4-methylenedioxymethamphetamine and (±)-3,4-methylenedioxyamphetamine in pigeons. Drug and Alcohol Dependence. 18. 159-164.
Glennon, R. A., Little, P. J., Rosecrans, J. A., & Yousif, M. (1987). The effects
o f MDMA ("Ecstasy") and its optical isomers on schedule-controlled
responding in mice. Pharmacology Biochemistry and Behavior. 26. 425-426.
Glennon, R. A., & Young, R. (1984). Further investigation o f the discriminative
stimulus properties o f MDA. Pharmacology Biochemistry and Behavior. 20,
501-505.
Gould, S. J. (1990, April). The war on (some) drugs. H arper's, pp. 24-26.
Heise, G. A., & Milar, K. S. (1984). Drugs and stimulus control. In L. L. Iversen,
S. D. Iversen, & S. H. Snyder (Eds.), Handbook of psychopharmacologv
(Vol. 18, pp. 129-190). New York: Plenum Press.
25

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

26
Kamien, J. B., Johanson, C. E., Schuster, C. R., & Woolverton, W. L. (1986).
The effects of (±)methylenedioxymethamphetamine and (±)methylenedioxyamphetamine in monkeys trained to discriminate (+)amphetamine from saline.
Drug and Alcohol Dependence. 18.139-147.
Kirsch, M. M. (1986). Designer drugs. Minneapolis: CompCare Publications
Lamb, R. J., & Griffiths, R. R. (1987). Self-injection o f d,/-3,4-methylenedioxy
methamphetamine (MDMA) in the baboon. Psvchopharmacology. 91. 268272.
Li, A. A., Marek, G. J., Vosmer, G., & Seiden, L. S. (1989). Long-term central 5HT depletions resulting from repeated administration of MDMA enhances the
effects o f single administration of MDMA on schedule-controlled behavior of
rats. Pharmacology Biochemistry and Behavior. 33. 641-648.
Lyon, R. A., Glennon, R. A., & Titeler, M. (1986). 3-4-Methylenedioxymethamphetamine (MDMA): Stereoselective interactions at brain 5-HTi and 5HT 2 receptors. Psvchopharmacology. 88. 525-526.
Maisto, S. A., Galizio, M., & Conners, G. J. (1991). Drug use and misuse.
Chicago: Holt, Rinehart, and Winston.
Moerschbaecher, J. M., Boren, J. J., Schrot, J., & Fontes, J. C. S. (1979). Effects
o f cocaine and d-amphetamine on the repeated aquisition performance of
conditional discriminations. Journal of the Experimental Analysis of
Behavior. 31. 127-140,
Nader, M. A., Hoffmann, S. M., & Barrett, J. E. (1989). Behavioral effects of
(±)3,4-methylenedioxyamphetamine (MDA) and (±)3,4-methylenedioxymeth
amphetamine (MDMA) in the pigeon: Interactions with noradrenergic and
serotonergic systems. Psvchopharmacology. 98. 183-188.
National Institute on Drug Abuse. (1988). National household survey on drug
abuse. Washington, DC: National Institute on Drug Abuse.
Payne, W. A., Hahn, D. B., & Pinger, R. R. (1991). Drugs: Issues for today.
Chicago: Mosby Year Book.
Peroutka, S. J. (1987). Incidence of recreational use of 3,4-methylenedioxymeth
amphetamine (MDMA, "Ecstasy") on an undergraduate campus. New
England Journal o f Medicine. 317. 1542-1543.
Rees, D. C., Wood, R. W., & Laties, V. G. (1987). Stimulus control and the
development of behavioral tolerance to daily injections of d-amphetamine in
the rat. Journal o f Pharmacology and Experimental Threrapeutics. 240. 6573.
Ricaurte, G. A., Forno, L. S., Wilson, M. A., De Lanney, L. E., Irwin, I., Molliver, M.
E., & Langston, J. W. (1988). (+)3,4-methylenedioxymethamphetamine
selectively damages central serotonergic neurons in non-human primates. Journal
o f the American Medical Association. 260. 51 -55.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

27
Rosecrans, J. A., & Glennon, R. A. (1987). The effect of MDA and MDMA
("Ecstasy") isomers in combination with pirenpirone on operant responding in
mice. Pharmacology Biochemistry and Behavior. 28. 39-42.
Schechter, M. D. (1986). Discriminative profile of MDMA. Pharmacology
Biochemistry and Behavior. 24. 1533-1537.
Schlaadt, R. G. (1992). Drugs, society, and behavior. Guilford, CT: Dushkin.
Schmidt, C. J. (1987). Neurotoxicity of the psychedelic amphetamine, methylene
dioxymethamphetamine. Journal of Pharmacology and Experimental
Therapeutics. 240. 1-7.
Schuster, C. R., Dockens, W. S., & Woods, J. H. (1966). Behavioral variables
affecting the development of amphetamine tolerance. Psvchopharmacologia.
9, 170-182.
Siegel, R. K. (1986). MDMA: Nonmedical use and intoxication. Journal of
Psvchoactive Drugs. 18. 291-300.
Snapper, A. G., & Inglis, G. (1978). The SKED software system: Time-shared
SUPERSKED. Kalamazoo, MI: State Systems.
Stone, D. M., Stahl, D. C., Hansen, G. R., & Gibb, J. W. (1986). The effects of
3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. European
Journal o f Pharmacology. 128. 41-48.
Thompson, D. M. (1986). Stimulus control and drug effects. In D. E. Sanger & D.
J. Blackman (Eds.) Contemporary research in behavioral pharmacology (pp.
159-208). Plenum: New York.
Thompson, D. M., Winsauer, P. J., & Mastropaolo, J. (1987). Effects of
phencyclidine, ketamine, and MDMA on complex operant behavior in
monkeys. Pharmacology Biochemistry and Behavior. 26. 401-405.
Witters, W., Venturelli, P., & Hanson, G. (1992). Drugs and society. Boston:
Jones and Bartlett.
Yousif, M. Y., Fitzgerald, R. L., Narasimhachari, N., Rosecrans, J. A., Blanke, R.
V., & Glennon, R. A. (1990). Identification of metabolites of 3,4methylenedioxymethamphetamine in rats. Drug and Alcohol Dependence. 26.
127-1135.
Zacny, J. P., Virus, R. M., & Woolverton, W. L. (1990). Tolerance and cross
tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine. Pharmacology Biochemistry and
Behavior. 35. 637-642.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

